HSBC Continental Europe
HSBC Continental Europe: Post Stabilisation Notice
HSBC Continental Europe: Post Stabilisation Notice
PARIS, July 23, 2025 (GLOBE NEWSWIRE) --
Post Stabilisation Notice
HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice that no stabilisation was undertaken by the Stabilisation Manager(s) named below in relation to the offer of the following securities.
Issuer: | Werfen, S.A. |
Guarantor (if any): | na |
Aggregate nominal amount: | EUR 500,000,000 |
Description: | 3.625% due 12th February 2032 |
Offer price: | 99.671 |
Stabilising Manager: | HSBC Continental Europe |
This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Evaxion25.7.2025 15:00:04 CEST | Press release
Evaxion to present two-year clinical efficacy data from phase 2 trial with AI-designed personalized cancer vaccine EVX-01 at the ESMO Congress 2025
eXp Realty25.7.2025 15:00:00 CEST | Press release
eXp Realty Launches in Japan, Marking Fourth Global Market Entry in 2025
Bitget Limited25.7.2025 14:56:37 CEST | Press release
Bitget’s GetAgent AI Trading Assistant Sees Explosive Adoption, Ignites Community Frenzy
Biogen Inc.25.7.2025 13:20:26 CEST | Press release
ZURZUVAE® (zuranolone) Receives Positive Opinion from CHMP for the Treatment of Women with Postpartum Depression
F. Hoffmann-La Roche Ltd25.7.2025 13:00:00 CEST | Press release
Roche provides regulatory update on Elevidys™ gene therapy for Duchenne muscular dystrophy in the EU
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom